Skip to main content

GOLDMAN SACHS GROUP INC

Position in PSNL — Personalis, Inc.

CIK 886982 NEW YORK, NY

Position in PSNL

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$12,475,815
+$7,780,285 QoQ
Shares Held
931,031
+26.3% QoQ
Ownership
0.872%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#18
of 157 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in PSNL Over Time

Shares Held

Position Value (USD)

Derivatives in PSNL

reported options exposure · as of Jun 30, 2026
CallValue
$3,199,920
CallShares
238,800
PutValue
$0
PutShares
0

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Diagnostics & Research

Healthcare · as of Jun 30, 2026

GOLDMAN SACHS GROUP INC holds $7,059,039,871 across 32 Diagnostics & Research names. PSNL ranks #25 (0.2% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in PSNL

Export CSV
27 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $3,199,920 238,800
2026-06-30 $12,475,815 931,031
2026-03-31 $4,695,530 737,132
2025-12-31 $2,726,100 342,475
2025-09-30 $3,742,355 573,981
2025-06-30 $1,375,408 209,666
2025-03-31 $998,335 284,426
2024-12-31 $1,056,121 182,720
2024-09-30 $228,612 42,493
2024-06-30 $52,433 44,815
2024-03-31 $107,835 72,373
2023-12-31 $197,492 94,044
2023-09-30 $54,221 44,811
2023-06-30 $88,937 47,307
2023-03-31 $208,598 75,579
2022-12-31 $176,666 89,226
2022-09-30 $239,043 80,486
2022-06-30 $691,928 200,559
2022-03-31 $1,533,962 187,297
2021-12-31 $2,526,916 177,079
2021-09-30 $4,041,534 210,059
2021-06-30 $3,648,689 144,217
2021-03-31 $6,218,503 252,682
2020-12-31 $4,662,100 127,345
2020-09-30 $2,707,882 124,960
2020-06-30 $608,084 46,884
2020-03-31 $401,877 49,799